20α,22R-Dihydroxycholesterol
20α,22R-Dihydroxycholesterol is a sterol and a cholesterol derivative that plays a significant role in the biosynthesis of steroid hormones. It is an intermediate in the conversion of cholesterol to pregnenolone, which is the precursor to all steroid hormones.
Structure and Properties[edit]

20α,22R-Dihydroxycholesterol is characterized by the presence of two hydroxyl groups at the 20α and 22R positions of the cholesterol backbone. This modification is crucial for its function in the steroidogenic pathway. The molecular formula of 20α,22R-Dihydroxycholesterol is C27H46O3, and it has a molecular weight of 418.65 g/mol.
Biosynthesis[edit]
The biosynthesis of 20α,22R-Dihydroxycholesterol occurs in the mitochondria of steroidogenic tissues such as the adrenal cortex, ovaries, and testes. The enzyme cholesterol side-chain cleavage enzyme (also known as CYP11A1) catalyzes the conversion of cholesterol to pregnenolone, with 20α,22R-Dihydroxycholesterol as an intermediate. This reaction involves the hydroxylation of cholesterol at the 20 and 22 positions, followed by the cleavage of the side chain.
Function[edit]
20α,22R-Dihydroxycholesterol is a critical intermediate in the production of pregnenolone, which is the first step in the synthesis of all steroid hormones, including glucocorticoids, mineralocorticoids, androgens, and estrogens. The regulation of this pathway is essential for maintaining hormonal balance and responding to physiological demands.
Clinical Significance[edit]
Disruptions in the production or function of 20α,22R-Dihydroxycholesterol can lead to disorders in steroid hormone synthesis. For example, mutations in the CYP11A1 gene can result in congenital adrenal hyperplasia, a condition characterized by impaired steroidogenesis and hormonal imbalances.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian